Therapy Area
“Intentional effort” needed from sponsors to achieve diversity in oncology clinical trials
The biopharma industry should be proactive in its approach to changing requirements for diversity in clinical trial populations.
Alzheimer’s trial doses patients with stem cell treatment directly to brain
Hanmi signs clinical trial collaboration with MSD
Hepion shelves Phase II NASH trial amid shallow cash resources
Krystal Biotech doses first subject in lung cancer drug trial
ASLAN reports interim data from atopic dermatitis drug trial
